Pharma companies are eager to invest in IVA development, but adoption among sales reps remains a challenge. A recent study shows that 62% of sales reps still rely on printed materials for promotions — a costly practice that can also expose the company to compliance risks. So, how can we integrate IVAs into sales reps' daily routines more effectively?
